Advanced Search

 

Study ID Status Title Patient Level Data
SMS40315 Completed A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel Group, 8-Week Comparison of Salmeterol Xinafoate Versus Ipratropium Bromide Versus Salmeterol Xinafoate Plus Ipratropium Bromide Versus Placebo in Subjects With Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
SMS40318 Completed Randomized, double blind, placebo-controlled, parallel-group trial over 4 weeks to evaluate the effect of salmeterol (2x50 µg/d by Diskus®) on the lung volumes at rest and during sub-maximal exercise in subjects with moderate chronic obstructive pulmonary disease (COPD)
SMS40320 Completed A Multi-Center, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of Salmeterol Xinafoate Inhalation Aerosol Versus Ipratropium Bromide and Albuterol Sulfate Inhalation Aerosol in Subjects With Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
SMS40321 Completed A Multi-Center, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of Salmeterol Xinafoate Inhalation Aerosol Versus Ipratropium Bromide and Albuterol Sulfate Inhalation Aerosol in Subjects With Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
SMS40329 Completed A Randomised, Single-Blind, Parallel-Group, 28-Day, Pilot Study to Compare the Addition of Inhaled Salmeterol 50µg bid (via the DISKHALER™ Inhaler) or Tulobuterol-Patch 2mg qd Nocte in Adult Asthmatic Subjects who are Symptomatic on Inhaled Corticosteroids Alone Study Listed on ClinicalStudyDataRequest.com
SMS40330 Completed A Randomized, Multi-Center, Cross Over Comparison of Salmeterol Xinafoate Inhalation Powder (50mcg BID) via the DISKUS ™ and Salmeterol Xinafoate Inhalation Aerosol (42mcg BID) via the Metered Dose Inhaler on Measures of Device Preference in Subjects with COPD Study Listed on ClinicalStudyDataRequest.com
SMS40332 Completed A randomised, open-label, parallel group 28-day pilot study to compare the addition of inhaled salmeterol 50mcg b.i.d. (via the DISKHALER inhaler) or tulobuterol patch 2mg once daily nocte in adult asthmatic subjects symptomatic on treatment with inhaled corticosteroids. Study Listed on ClinicalStudyDataRequest.com
SMT-06-91 Completed Double blind, placebo-controlled, cross-over study to assess the safety and efficacy of repeated oral doses of sumatriptan (GR43175C) 100mg (plus two optional oral doses of sumatriptan (GR43175C) 100mg) in the acute treatment of migraine.
Sn408D/06 Completed Assessment of efficacy and safety of Serevent™ Diskus™plus Flutide (Flixotide)™ Diskus™ combination therapy for adult bronchial asthma
SNA10001 Completed A randomised, double blind, placebo controlled, three-way cross-over study in asymptomatic patients with seasonal allergic rhinitis to compare the effect of 7 days treatment with intranasal salmeterol/fluticasone propionate combination ( 100mcg/200mcg) with 7 days treatment of fluticasone propionate (200mcg) or placebo, on nasal clinical symptoms and nasal blockage following intranasal allergen challenge. Study Listed on ClinicalStudyDataRequest.com
SND 103285 Completed A Ten-Week, Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Flexible-Dose Study Evaluating the Efficacy, Safety, and Tolerability of GSK372475 (1.5 mg/day to 2.0 mg/day) or Extended Release Venlafaxine XR (150 mg/day to 225 mg/day) Compared to Placebo in adult s
SND 103288 Completed A Ten-week, Multicenter, Randomized, Double-Blind, Placebo-and Active-Controlled, Paralleled-Group, Flexible-Dose study Evaluating the Efficacy, Safety and Tolerability of GSK372475 or Paroxetine Compared to Placebo in Adult Subjects Diagnosed with Major Depressive Disorder
SNS-D920619 Completed Serevent Nationwide Surveillance (SNS) Trial
SPD707-104 Completed A study to evaluate immunogenicity, safety and tolerance of three formulations of Fluviral®S/F influenza vaccine and Vaxigrip® in healthy adults 50-64 years of age and 65 years of age or older
SPE111154 Completed A single blind, randomised, placebo controlled, single ascending dose study to evaluate the safety, tolerability and pharmacokinetics of GSK958108 in healthy male subjects
S-RHS00289 Completed An Open-Label, Single-Dose and Multi-Dose Pharmacokinetic Study of 2mg and 4mg Nicotine Lozenge in Chinese Smokers
SRT-501-006 Completed A placebo-controlled pharmacokinetic and safety study of twice daily SRT501 in type 2 diabetic human male subjects Study Listed on ClinicalStudyDataRequest.com
STA106711 Completed Imigran STATdose - Japan clinical experience study for self-injection
STQ105938 Completed A Phase II, multi-centre, open-label, randomised study to evaluate the safety, tolerability and pharmacokinetics of oral sitamaquine compared with amphotericin B in the treatment of visceral leishmaniasis caused by L. donovani in endemic areas.
SUM S2BL 25 Completed Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis.Extensive searching has revealed that no clinical study report is available for this study.
SUM01 Completed A study to evaluate the excretion of a 6mg subcutaneous dose of sumatriptan into breast milk.
SUM10914 Completed A study to investigate intra-subject variability and sex differences in the pharmacokinetics of 100mg sumatriptan following oral dosing.
SUM10922 Completed A study to evaluate the safety, tolerability and pharmacokinetics of sumatriptan (GR43175) following repeat administration intranasally.
SUM10923 Completed A study to assess the pharmacokinetic and pharmacodynamic profile of intranasal sumatriptan at doses of 5 mg, 10 mg and 20 mg.
SUM10931 Completed Evaluation of the pharmacokinetics and safety of ascending oral doses of GR43175C administered to healthy male volunteers.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.